Approvals for new drugs dropped to a six-year low in 2016. Industry insiders are optimistic that the recently passed 21st Century Cures Act will speed up the process. Download the PDF.
Data Points: Sharp drop-off in new drugs approved
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.